About Us

WHAT IF...

the right blend of people plus pharmaceutical innovation could provide solutions to redefine today’s medicines? At Innocoll, our focus on engineering collagen-based products and medicines—for better patient outcomes—begins with our people.


Innocoll is dedicated to making better happen – striving to engineer better medicines to transform today’s treatment approaches.

Our proprietary, biocompatible, and biodegradable collagen-based products are engineered for targeted use. Applied locally, they are designed to provide a range of treatment benefits.

Our late-stage product pipeline is focused on addressing the significant unmet medical need for postsurgical pain management. XARACOLL, a bupivacaine HCI collagen-matrix implant, has been studied in two Phase III clinical trials for postsurgical analgesia as a part of multi-modal therapy for patients undergoing hernia repair.

Our currently approved products include: COLLAGUARD® (ex-US), COLLATAMP® G, SEPTOCOLL® E, REGENEPRO®, COLLACARE®, COLLEXA®, and ZORPREVA®, some of which are sold globally through strategic partnerships. All of our collagen products—from extraction/purification of Type 1 collagen through final delivery— are manufactured at our certified, integrated plant in Saal, Germany.

“As we look toward the future, the success of Innocoll is predicated on continuing to deliver inspired innovation through targeted solutions that help make today’s medicines work better. By designing innovative site-specific treatment options, we’re bringing that vision to light: improving patient lives and enhancing outcomes—and fulfilling our promise of making better happen.”

– Anthony Zook, CEO, Innocoll

Our Manufacturing


Since 1985, Innocoll has ensured consistency and quality of all of its products by engineering and manufacturing within its own facility in Saal, Germany.

We recently fully integrated our manufacturing capabilities at our newly constructed state-of-the-art facility, beginning with the extraction and purification of the Type 1 collagen (from bovine and equine Achilles tendons), which is further processed using one of our proprietary technologies to produce final finished products in the forms of matrices, films, powders, liquids, and gels. Our facility in Germany is cGMPs compliant. The facility is also ISO 13485 certified.

Our Locations


USA

Innocoll Inc.

3803 West Chester Pike
Newtown Square, PA 19073
United States
Phone: +1 (484) 406-5200
E-mail: info@innocoll.com

IRELAND

Innocoll Pharmaceuticals

Unit 9, Block D
Monksland Business Park
Monksland
Athlone
Co. Roscommon
Ireland
Phone: +353 (0) 90 6486834
Fax: +353 (0) 90 6486835
E-mail: info@innocoll.com

GERMANY

Syntacoll GmbH

Industriegebiet Saal
Donaustraße 24
93342 Saal/Donau
Germany
Phone: +49 (0) 9441 6860 0
Fax: +49 (0) 9441 6860 30
E-mail: info@syntacoll.de

Business Development Group
Unit 9, Block D
Monksland Business Park
Monksland
Athlone
Co. Roscommon
Ireland
Phone: +353 (0)90 648 6834
Fax: +353 (0)90 648 6835
E-mail: businessdevelopment@innocoll.com

Innocoll Engineering Better Medicines logo and other brands are trademarks of Innocoll Pharmaceuticals. © 2016. Innocoll Holdings plc, is registered in Ireland as a public limited company with registration number 544604 and has its registered office at Unit 9, Block D, Monksland Business Park, Monksland, Athlone, Co. Roscommon, Ireland.